Fig. 7

VNP-shCCDC25 stimulated DCs maturation. A, B The percentage of CD80 positive cells in tumor-infiltrating DCs was analyzed via FACS. C, D The percentage of CD11b positive cells in tumor-infiltrating DCs was analyzed via FACS. E, F 5 days after administrations, the level of CD103 in DCs in peripheral blood was analyzed via FACS. G The percentage of DCs in TdLNs. And the statistic diagrams were shown in (H). I, J In TdLNs, the percentage of CD80⁺DCs was analyzed via FACS. K, L Similarly, CD8⁺ DCs in TdLNs was evaluated. Data are shown as the mean ± SD. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, ns: no significance